Literature DB >> 27251210

IBD: Exposure to anti-TNF agents in utero: controlling health risks.

C Janneke van der Woude1, Shannon L Kanis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27251210     DOI： 10.1038/nrgastro.2016.94

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  9 in total

1.  Adalimumab level in breast milk of a nursing mother.

Authors:  Shomron Ben-Horin; Miri Yavzori; Lior Katz; Orit Picard; Ella Fudim; Yehuda Chowers; Alon Lang
Journal:  Clin Gastroenterol Hepatol       Date:  2010-01-06       Impact factor: 11.382

Review 2.  The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease.

Authors:  C J van der Woude; S Ardizzone; M B Bengtson; G Fiorino; G Fraser; K Katsanos; S Kolacek; P Juillerat; A G M G J Mulders; N Pedersen; C Selinger; S Sebastian; A Sturm; Z Zelinkova; F Magro
Journal:  J Crohns Colitis       Date:  2015-02       Impact factor: 9.071

3.  Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease.

Authors:  Kuldeep Cheent; Jonathan Nolan; Sohail Shariq; Liina Kiho; Arabinda Pal; Jayantha Arnold
Journal:  J Crohns Colitis       Date:  2010-06-09       Impact factor: 9.071

4.  Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease.

Authors:  Shomron Ben-Horin; Miri Yavzori; Uri Kopylov; Orit Picard; Ella Fudim; Rami Eliakim; Yehuda Chowers; Alon Lang
Journal:  J Crohns Colitis       Date:  2011-12       Impact factor: 9.071

5.  Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety.

Authors:  A de Lima; Z Zelinkova; C van der Ent; E A P Steegers; C J van der Woude
Journal:  Gut       Date:  2015-05-12       Impact factor: 23.059

Review 6.  The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy.

Authors:  Geoffrey C Nguyen; Cynthia H Seow; Cynthia Maxwell; Vivian Huang; Yvette Leung; Jennifer Jones; Grigorios I Leontiadis; Frances Tse; Uma Mahadevan; C Janneke van der Woude
Journal:  Gastroenterology       Date:  2015-12-11       Impact factor: 22.682

7.  Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.

Authors:  Bindia Jharap; Nanne K H de Boer; Pieter Stokkers; Daniel W Hommes; Bas Oldenburg; Gerard Dijkstra; C Janneke van der Woude; Dirk J de Jong; Chris J J Mulder; Ruurd M van Elburg; Adriaan A van Bodegraven
Journal:  Gut       Date:  2013-02-19       Impact factor: 23.059

8.  Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.

Authors:  Uma Mahadevan; Douglas C Wolf; Marla Dubinsky; Antoine Cortot; Scott D Lee; Corey A Siegel; Thomas Ullman; Sarah Glover; John F Valentine; David T Rubin; Jocelyn Miller; Maria T Abreu
Journal:  Clin Gastroenterol Hepatol       Date:  2012-11-28       Impact factor: 11.382

9.  Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection.

Authors:  Mette Julsgaard; Lisbet A Christensen; Peter R Gibson; Richard B Gearry; Jan Fallingborg; Christian L Hvas; Bo M Bibby; Niels Uldbjerg; William R Connell; Ourania Rosella; Anne Grosen; Steven J Brown; Jens Kjeldsen; Signe Wildt; Lise Svenningsen; Miles P Sparrow; Alissa Walsh; Susan J Connor; Graham Radford-Smith; Ian C Lawrance; Jane M Andrews; Kathrine Ellard; Sally J Bell
Journal:  Gastroenterology       Date:  2016-04-08       Impact factor: 22.682
  9 in total
  2 in total

Review 1.  Update on biologic safety for patients with psoriasis during pregnancy.

Authors:  Martina L Porter; Stephen J Lockwood; Alexa B Kimball
Journal:  Int J Womens Dermatol       Date:  2017-02-04

Review 2.  Biologic therapies for Crohn's disease: optimising the old and maximising the new.

Authors:  Mark Samaan; Samantha Campbell; Georgina Cunningham; Aravind Gokul Tamilarasan; Peter M Irving; Sara McCartney
Journal:  F1000Res       Date:  2019-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.